Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Rozeman, EA (author)

Menzies, AM (author)

van Akkooi, ACJ (author)

show more...

Adhikari, C (author)

Bierman, C (author)

van de Wiel, BA (author)

Scolyer, RA (author)

Krijgsman, O (author)

Sikorska, K (author)

Eriksson, H (author)

Karolinska Institutet

Broeks, A (author)

van Thienen, JV (author)

Guminski, AD (author)

Acosta, AT (author)

ter Meulen, S (author)

Koenen, AM (author)

Bosch, LJW (author)

Shannon, K (author)

Pronk, LM (author)

Gonzalez, M (author)

Ch'ng, S (author)

Grijpink-Ongering, LG (author)

Stretch, J (author)

Heijmink, S (author)

van Tinteren, H (author)

Haanen, JBAG (author)

Nieweg, OE (author)

Klop, WMC (author)

Zuur, CL (author)

Saw, RPM (author)

van Houdt, WJ (author)

Peeper, DS (author)

Spillane, AJ (author)

Hansson, J (author)

Karolinska Institutet

Schumacher, TN (author)

Long, GV (author)

Blank, CU (author)

show less...

 (creator_code:org_t)

2019

2019

English.

In: The Lancet. Oncology. - 1474-5488. ; 20:7, s. 948-960

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)